Utidelone can penetrate BBB due to its unique physicochemical characteristics and insusceptibility to P-glycoprotein-mediated efflux
Felzartamab demonstrated positive interim results from the Phase 2 IgA nephropathy (IgAN) study
Aim of the collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization
Dyslipidemia is a critical risk factor for cardiovascular diseases
The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
The Unit has now received Establishment Inspection Report classifying the facility as Voluntary Action Indicated
This Unit of Shilpa Medicare is engaged in testing biological samples of clinical studies
Combined entity is better positioned to compete in increasingly competitive generics industry
Ascentage Pharma announces confidential submission of draft registration statement for proposed IPO
_256_384.jpg)
The company will work closely with the USFDA and is committed to address these comprehensively within stipulated time
Subscribe To Our Newsletter & Stay Updated
